Edgewise Therapeutics (EWTX) is up 18.1%, or $5.70 to $37.15.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EWTX:
- Cytokinetics report ‘arguably a best-case scenario’ for Edgewise, says Stifel
- Cytokinetics Phase 3 data bodes well for Edgewise, says Raymond James
- Edgewise Therapeutics rises 23.3%
- Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
- JPMorgan ups Edgewise target, adds to Analyst Focus List